CFTR and alkaline phosphatase measurement: In patients with AP, the gene mutations detected compared with the controls were as follows: SPINK1, 6.3 % patients versus 3.2 % controls; CFTR, 2.3 % patients versus 3.8 % controls; and CTRC, 1.8 % patients versus 1.2 % controls (Table 3).